Analysis of BENCHMRK 1 & 2 using PhenoSense® assay for darunavir (DRV/r) resistance and exploration of functional monotherapy with RAL vs DRV

Podobne zapisy

• Low-level viraemia during treatment with darunavir/r monotherapy versus DRV/r + 2NRTIs in the MONET trial
  od: Clumeck, N, i wsp.
  Wydane: (2010)
• Comparison of the Precision and Sensitivity of the Antivirogram and PhenoSense HIV Drug Susceptibility Assays
  od: Zhang, Jie, i wsp.
  Wydane: (2005)
• Analysis of major and minor IAS-USA PI mutations in the MONET trial of darunavir/ritonavir monotherapy versus DRV/r + 2NRTIs
  od: Pulido, F, i wsp.
  Wydane: (2010)
• Weak Agreement between Antivirogram and PhenoSense Assays in Predicting Reduced Susceptibility to Antiretroviral Drugs
  od: Wang, Kai, i wsp.
  Wydane: (2004)
• Susceptibility of global HIV-1 clinical isolates to fostemsavir using the PhenoSense(®) Entry assay
  od: Gartland, Margaret, i wsp.
  Wydane: (2020)